Γ

SynBioBeta Speaker

Tommi White

Bayer Crop Science

Structure & Mech. Team Lead

Trained as a biochemist, Tommi White has broad expertise in structural biology, enzymology, analytical imaging and protein design. She studied flavoenzyme structure-function using X-ray protein crystallography, where she was awarded Donald K. Anderson Outstanding Graduate Research Assistant. She was a Cancer Research Training Award recipient at the National Cancer Institute at NIH working towards developing neutralizing antibodies against viral envelope glycoproteins using cryo-electron microscopy.  Prior to joining Bayer Crop Science, Tommi lead the Electron Microscopy Core Research Facility as Director & Research Assistant Professor in Biochemistry at University of Missouri. While there, she significantly improved scientific capabilities, built strong relationships and fostered collaborations while mentoring numerous students, igniting their passion for electron microscopy to study their systems at the nanoscale. During her leadership, she co-authored over 40 publications, culminating in a $32M partnership with electron microscope manufacturer, ThermoFisher Scientific, adding 8 new electron microscopes and establishing University of Missouri's Electron Microscopy Core as the most powerful, cutting-edge electron microscopy facility in the Midwest.   Currently at Bayer Crop Science, Tommi is leading discovery’s molecular characterization of insecticidal and herbicide tolerance traits as the Structure & Mechanism Team Lead. She uses many tools to do this, including in silico folding while developing the Protein Science AI Strategy and driving innovation to implement new technologies. She interfaces with many parts of the organization and continues to build relationships through numerous leadership initiatives both internally and externally. She stays connected to the academic community through the University Mentoring Program by Bayer (B4U) which provides professional development to later stage graduate students and post-doctoral fellows through a year of 1:1 mentoring. Her talk will cover "AI‑Enabled Protein Design for Crop Traits" and how she and colleagues are using AI technologies to design next-gen protein traits for sustainable agriculture.

Sessions Featuring

Tommi

This Year

Breakout Session

3:30 PM

-

4:15 PM

Planetary Health

From Discovery to Field: How Bayer Crop Science R&D Turns Innovation into Solutions for Farmers

Join Bayer Crop Science researchers and innovators for a hybrid presentation and panel discussion exploring how cutting-edge R&D is transforming agricultural innovation. Speakers will cover AI foundation models and multimodal approaches for trait discovery, AI-enabled protein design for herbicide tolerance and insect control, next-generation crop protection strategies for new modes of action, and leveraging open innovation to advance Bayer's biologicals portfolio. The session concludes with a moderated panel discussion on the future of agricultural science and its impact on farmers worldwide.

Breakout Session

3:30 PM

-

4:15 PM

Planetary Health

From Discovery to Field: How Bayer Crop Science R&D Turns Innovation into Solutions for Farmers

Join Bayer Crop Science researchers and innovators for a hybrid presentation and panel discussion exploring how cutting-edge R&D is transforming agricultural innovation. Speakers will cover AI foundation models and multimodal approaches for trait discovery, AI-enabled protein design for herbicide tolerance and insect control, next-generation crop protection strategies for new modes of action, and leveraging open innovation to advance Bayer's biologicals portfolio. The session concludes with a moderated panel discussion on the future of agricultural science and its impact on farmers worldwide.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include